Cigna Group (NYSE: CI) director receives 782-share stock grant

Rhea-AI Filing Summary

Ross Kimberly A. reported acquisition or exercise transactions in this Form 4 filing.

Cigna Group director Kimberly A. Ross received a stock award of 782 shares of Common Stock on April 22, 2026. The shares were granted at no stated purchase price, reflecting compensation rather than a market purchase.

After this award, Ross directly owns 5,294 shares of Cigna Group Common Stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ross Kimberly A.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $.01 Par Value	782	$0.00	--

Holdings After Transaction: Common Stock, $.01 Par Value — 5,294 shares (Direct, null)

Footnotes (1)

Key Figures

Shares granted: 782 shares Price per granted share: $0.0000 per share Total shares after transaction: 5,294 shares +2 more

5 metrics

Shares granted 782 shares Common Stock grant on April 22, 2026

Price per granted share $0.0000 per share Grant, award, or other acquisition

Total shares after transaction 5,294 shares Direct holdings following the grant

Transaction code A Grant, award, or other acquisition of Common Stock

Transaction date April 22, 2026 Date of stock grant to director Ross

Key Terms

Common Stock, $.01 Par Value, Grant, award, or other acquisition, Form 4, transaction code A

4 terms

Common Stock, $.01 Par Value financial

"security_title: Common Stock, $.01 Par Value"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction code A regulatory

"transaction_code: "A""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ross Kimberly A.

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CONNECTICUT 06002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	04/22/2026		A		782	A	$0	5,294	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

	Tyler Gratton, attorney-in-fact	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Cigna Group (CI) report for Kimberly A. Ross?

Cigna Group reported that director Kimberly A. Ross received a grant of 782 shares of Common Stock. The shares were acquired at no stated purchase price as part of a grant, increasing her direct ownership to 5,294 shares following the transaction.

Was the Cigna Group (CI) insider transaction a market purchase or a grant?

The transaction was a grant, not a market purchase. Form 4 shows code “A” with the description “Grant, award, or other acquisition,” and the 782 shares of Common Stock were reported at a price of $0.0000 per share.

How many Cigna Group (CI) shares does Kimberly A. Ross own after this Form 4?

After the reported grant, Kimberly A. Ross directly owns 5,294 shares of Cigna Group Common Stock. This figure includes the 782-share award reported in the Form 4 and represents her direct holdings following the transaction on April 22, 2026.

What is the transaction code used in the Cigna Group (CI) Form 4 filing?

The Form 4 filing uses transaction code “A,” which is described as “Grant, award, or other acquisition.” This code indicates the 782 Cigna Group Common Stock shares were received as a grant rather than bought or sold in the open market.

Did Kimberly A. Ross sell any Cigna Group (CI) shares in this Form 4?

No sales were reported in this Form 4. The filing shows a single acquisition transaction coded “A” for 782 shares as a grant, and the transaction summary indicates zero sell transactions and a net buy/sell direction classified as neutral.